- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
AlloVir (NASDAQ:ALVR), Quotes and News Summary
AlloVir (NASDAQ: ALVR)
Earnings
see more| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-11-04 | ||||||
| REV | |||||||
| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.730 | -0.690 | 0.0400 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
AlloVir Questions & Answers
You can purchase shares of AlloVir (NASDAQ: ALVR) through any online brokerage.
Other companies in AlloVir’s space includes: Immunovant (NASDAQ:IMVT), Kezar Life Sciences (NASDAQ:KZR), Immatics (NASDAQ:IMTX), Pharming (NASDAQ:PHAR) and Adicet Bio (NASDAQ:ACET).
The latest price target for AlloVir (NASDAQ: ALVR) was reported by SVB Leerink on Thursday, July 28, 2022. The analyst firm set a price target for 23.00 expecting ALVR to rise to within 12 months (a possible 183.43% upside). 9 analyst firms have reported ratings in the last year.
The stock price for AlloVir (NASDAQ: ALVR) is $8.115 last updated Today at August 10, 2022, 2:07 PM UTC.
There are no upcoming dividends for AlloVir.
AlloVir’s Q3 earnings are confirmed for Friday, November 4, 2022.
There is no upcoming split for AlloVir.
AlloVir is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.